Attractive Opportunities in Vascular Access Device Market as Technological Advancements in Medical Industry

The ****** vascular access device market is projected to grow from USD 3.87 Billion in 2017 to reach to USD 5.45 Billion by 2022 at a CAGR of 7.1%. Base year considered for the report is 2016.

Download FREE Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686

Vascular access devices include central vascular access devices, peripheral vascular access devices, and accessories.

The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

Top Key Players in Vascular Access Devices Market

The major players in this market include Major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C.R.Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B.Braun Melsungen Ag (Germany), Angiodynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodi med (France).

Target Audience:

  • Vascular access device manufacturers and distributors
  • Interventional cardiology vascular device manufacturers
  • Research and consulting firms
  • Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
  • Research institutes
  • Vendors/service providers
  • Niche companies manufacturing novel vascular access devices
  • Research and consulting firms

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices

Read More @
https://www.marketsandmarkets.com/PressReleases/vascular-access-device.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of ****** Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking ****** high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com